Impact of a ground-glass opacity component on c-stage IA lung adenocarcinoma
Studies have shown that tumors with ground-glass opacity (GGO) components are associated with favorable outcomes. However, this view should be confirmed in an international cohort. We aimed to verify the impact of a GGO component on clinical (c)-stage IA lung adenocarcinoma and to describe the biological discrepancies between the part-solid and pure-solid groups. We evaluated 1333 cases of surgically resected c-stage IA lung adenocarcinomas, including 484 part-solid and 849 pure-solid tumors. Furthermore, we matched the solid size between the two groups and examined 470 patients.
Source: Seminars in Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Ming Li, Junjie Xi, Qihai Sui, Hiroaki Kuroda, Kazutoshi Hamanaka, Stefano Bongiolatti, Goohyeon Hong, Cheng Zhan, Mingxiang Feng, Qun Wang, Lijie Tan Tags: THORACIC – Original Submission Source Type: research
More News: Adenocarcinoma | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Heart | Study